FLSM
IMCR icon

Frazier Life Sciences Management’s Immunocore IMCR Stock Holding History

Frazier Life Sciences Management’s Portfolio IMCR Stock Details IMCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$15.4M Hold
484,782
– – 0.34% 36
2026
Q1 		$14.6M Buy
484,782
+100,000
+26% +$3.24M 0.38% 30
2025
Q4 		$13.4M Hold
384,782
– – 0.36% 33
2025
Q3 		$14M Hold
384,782
– – 0.42% 35
2025
Q2 		$12.1M Buy
384,782
+83,612
+28% +$2.6M 0.48% 37
2025
Q1 		$8.94M Buy
301,170
+192,408
+177% +$5.77M 0.41% 32
2024
Q4 		$3.21M Hold
108,762
– – 0.13% 50
2024
Q3 		$3.39M Hold
108,762
– – 0.14% 50
2024
Q2 		$3.69M Buy
+108,762
New +$5.55M 0.17% 47

Other funds holding IMCR

Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

Frazier Life Sciences Management's IMCR Position: Q2 2026 in Review

Frazier Life Sciences Management held its Immunocore (IMCR) position steady in Q2 2026 at 484,782 shares worth $15.4M. The position accounts for 0.34% of the portfolio, ranked #36.

Frazier Life Sciences Management first reported a position in IMCR in Q2 2024 and has held it in 9 quarters since. 136 funds tracked by Wall St. Rank hold IMCR as of Q2 2026.

  • Frazier Life Sciences Management held 484,782 shares of Immunocore worth $15.4M as of Q2 2026.
  • Frazier Life Sciences Management left its Immunocore share count unchanged in Q2 2026.
  • Immunocore made up 0.34% of Frazier Life Sciences Management's portfolio in Q2 2026, its #36 holding.
  • Frazier Life Sciences Management first reported a position in Immunocore in Q2 2024 and has held it in 9 quarters since.
  • 136 funds tracked by Wall St. Rank held Immunocore as of Q2 2026.

Based on Frazier Life Sciences Management's 13F filing for Q2 2026, filed 14 Aug 2026.